This guidance is for the management of smoking cessation for people with mental illness, living in Australia and Aotearoa New Zealand.
Evidence based advice provided on all smoking cessation strategies including:
- Therapeutic Goods Administration (TGA) approved pharmacotherapies
- behavioural interventions
- use of nicotine vaping products.
Also included is advice for clinicians on promoting the key benefits of smoking cessation to their patients, including the effects on physical and mental health and risks to the developing brain.